Novartis Investigative Site
Covilha 6200-251
0 studies enrolling now · 4 studies all time
What they study most
Acute Heart Failure, Acute Myocardial Infarction, Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure With Reduced Ejection Fraction
Studies at this site
- Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
- Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
- Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
- Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed